Jafron Biomedical financials at a glance

The revenue of Jafron Biomedical is reported as 1.92235 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0.52 Yuan Renminbi per share in 2023, which was 49.51 lower than 2022. And about 0.66949 billion Yuan Renminbi are reported as free cash flow in the financials of Jafron Biomedical 2023. Dividends of 0.4 Yuan Renminbi per share were paid to shareholders of Jafron Biomedical stock SZSE:300529 in fiscal 2023.